177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience | Journal of Nuclear Medicine

177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience | Journal of Nuclear Medicine

Comments

Popular posts from this blog

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Dr. Christopher Kane of UCSD Health Appointed Chairman of the American Board of Urology

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily